Heath Thomas, DVM, PhD, DACVP

Dr. Thomas the President of Aclairo Pharmaceutical Development, a consultancy focused on drug discovery and development. Dr. Thomas is a board-certified veterinary pathologist with over 20 years of experience in drug development from time spent with SmithKline Beecham, Dupont Pharmaceuticals and GlaxoSmithKline as well as several years of consulting experience with Experimental Pathology Laboratories. He […]

Dipak Panigrahy, MD

Dr. Panigrahy is the world’s leading expert in Resolvin pharmacology in cancer. He is an Assistant Professor of Pathology at Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital affiliated with Harvard Medical School. His laboratory, which is located in the Center for Vascular Biology Research at BIDMC, has deep expertise in multiple animal models […]

Pushpa Singh, PhD

Dr. Singh is a Pharmaceutical R&D executive with over 30+ years of experience in all phases of product development including discovery, development, technology transfer, and product life-cycle management. As a Vice President, Quality Operations & CMC Regulatory at Keryx Biopharmaceuticals, she was responsible for the overall strategic and operational activities in ensuring quality and regulatory […]

Robert Guttendorf, PhD

Dr. Guttendorf has over 25 years of experience directing preclinical and clinical DMPK programs, including regulatory interactions, in large pharmaceutical and small biotech companies. He has directed ADME/PK/Clinical Pharmacology from discovery through NDA, across therapeutic areas, with numerous regulatory submissions. He held leadership positions at Parke-Davis and Pfizer, and most recently was Vice President at Advancis […]

Jeff Moehlenkamp, PhD

Dr. Moehlenkamp brings over 16 years of development experience with Bristol-Myers Squibb. He has a PhD in pharmacology and is a board certified toxicologist. He has extensive study director/monitor experience, led or supported multiple small and large molecule development programs within diverse therapeutic areas, demonstrated expertise in developing compounds in virology, performed nonclinical safety due […]